Filing status
- Accounts due
- 31 December 2026
- Last accounts
- 31 March 2025
- Conf. stmt due
- 30 June 2027
- Last conf. stmt
- 16 June 2026
Gammadelta Therapeutics Ltd
- Incorporated
- 17 June 2016 (10 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Owned by
- Takeda Pharmaceutical Company Limited
- Accounts type
- Full
- Region
- Greater London
- Address
- 1 Kingdom StreetLondonW2 6BD
Charges
- Total
- 1
- Outstanding
- 0
- Part satisfied
- 0
- Satisfied
- 1
Officers 3 active
Officer details are public data from the Companies House register.
Director · Appointed 1 August 2022
Turkish
Born March 1979 (47)
Driscoll, Bryan
Secretary · Appointed 5 April 2022
British
Born March 1972 (54)
Officer history (12 former)
18 January 2023
8 November 2022
1 August 2022
22 July 2022
Resigned Huet, Heather Adkins, Dr as Director
5 April 2022
Resigned Paoletti, Paolo, Dr as Director
5 April 2022
5 April 2022
5 April 2022
Resigned Owen, Michael John as Director
5 April 2022
5 April 2022
5 April 2022
5 April 2022
Resigned Goodfellow, Peter Neville as Director
5 April 2022
Appointed Driscoll, Bryan as Secretary
1 April 2021
Resigned Kemp, Daniel Matthew as Director
1 April 2021
Appointed Huet, Heather Adkins, Dr as Director
9 June 2017
Resigned Parker, Stephen Barry, Dr as Director
8 May 2017
Appointed Kemp, Daniel Matthew as Director
9 February 2017
9 February 2017
Appointed Paoletti, Paolo, Dr as Director
9 September 2016
9 September 2016
Appointed Parker, Stephen Barry, Dr as Director
9 September 2016
Resigned Shields, John Gerard, Dr as Director
15 August 2016
Appointed Shields, John Gerard, Dr as Director
15 August 2016
Appointed Owen, Michael John as Director
15 August 2016
15 August 2016
Appointed Goodfellow, Peter Neville as Director
17 June 2016
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Takeda Pharmaceutical Company Limited
Corporate entity · Notified 8 May 2017
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Corporation
Reg. no. 1200-01-077461
Former controllers (2)
5 April 2022
Ceased Abingworth Bioventures VI GP LP — Owns 25–50% of shares
24 July 2017
Ceased Abingworth LLP — Owns 25–50% of shares
Filings 129
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 25 September 2026 | Director's details changed | |||
| 21 June 2026 | Confirmation statement with no updates | 16 June 2026 | ||
| 18 April 2026 | Full accounts | 31 March 2025 | ||
| 18 July 2025 | Full accounts | 31 March 2024 | ||
| 19 June 2025 | Confirmation statement with no updates | 16 June 2025 |
Some other companies at this address
Other companies in this industry
Sandwich
Newcastle Upon Tyne
Edinburgh
Edinburgh
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →